Abstract
We studied the elimination of sulfisoxazole in eight renal transplant patients. The patients received sulfisoxazole prophylactically for urinary tract infection commencing 7 days postoperatively. The renal elimination of sulfisoxazole (unbound renal clearance) was decreased in this patient population and was highly correlated with creatinine clearance. The unbound metabolic clearance and apparent unbound formation clearance of N4-acetyl sulfisoxazole did not differ from values found in healthy volunteers. The protein binding was marginally lower in this patient population than in healthy subjects after a single dose. The reduced binding was compatible with a reduced albumin concentration. In contrast to the situation for healthy subjects, the binding of sulfisoxazole decreased upon multiple dosing. This is probably due to a relatively higher sulfisoxazole and N4-acetyl sulfisoxazole-to-albumin ratio in this patient population than in healthy subjects. No complications of sulfisoxazole therapy were seen, although in three subjects concentration of the N4-acetyl sulfisoxazole in urine exceeded its theoretical solubility on a few occasions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appel G. B., Neu H. C. The nephrotoxicity of antimicrobial agents (third of three parts). N Engl J Med. 1977 Apr 7;296(14):784–787. doi: 10.1056/NEJM197704072961404. [DOI] [PubMed] [Google Scholar]
- Ascher N. L., Simmons R. L., Marker S., Najarian J. S. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan;113(1):90–94. doi: 10.1001/archsurg.1978.01370130092018. [DOI] [PubMed] [Google Scholar]
- Avram M. M., Nair S. R., Lipner H. I., Cherubin C. E. Persistent nocardemia following renal transplantation. Association with pulmonary nocardiosis. JAMA. 1978 Jun 30;239(26):2779–2780. doi: 10.1001/jama.239.26.2779. [DOI] [PubMed] [Google Scholar]
- Bekersky I., Colburn W. A. Acetylation of sulfisoxazole by isolated perfused rat kidney. J Pharm Sci. 1980 Nov;69(11):1359–1359. doi: 10.1002/jps.2600691135. [DOI] [PubMed] [Google Scholar]
- Cohen M. L., Weiss E. B., Monaco A. P. Successful treatment of Pneumocystis carinii and Nocardia asteroides in a renal transplant patient. Am J Med. 1971 Feb;50(2):269–276. doi: 10.1016/0002-9343(71)90156-2. [DOI] [PubMed] [Google Scholar]
- Jung D., Oie S. "High-pressure" liquid chromatography of sulfisoxazole and N4-acetylsulfisoxazole in body fluids. Clin Chem. 1980 Jan;26(1):51–54. [PubMed] [Google Scholar]
- Oie S., Gambertoglio J. G., Fleckenstein L. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing. J Pharmacokinet Biopharm. 1982 Apr;10(2):157–172. doi: 10.1007/BF01062333. [DOI] [PubMed] [Google Scholar]
- Reidenberg M. M., Kostenbauder H., Adams W. P. Rate of drug metabolism in obese volunteers before and during starvation and in azotemic patients. Metabolism. 1969 Mar;18(3):209–213. doi: 10.1016/0026-0495(69)90040-7. [DOI] [PubMed] [Google Scholar]
- Rieder J. Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy. 1972;17(1):1–21. doi: 10.1159/000220833. [DOI] [PubMed] [Google Scholar]
- Yacobi A., Levy G. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats. J Pharm Sci. 1977 Sep;66(9):1285–1288. doi: 10.1002/jps.2600660920. [DOI] [PubMed] [Google Scholar]